These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 29970697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G, Liu K, Du X.
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
    Yu X, Hu L, Li S, Shen J, Wang D, Xu R, Yang H.
    Cell Death Dis; 2019 Mar 25; 10(4):280. PubMed ID: 30911001
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.
    Wang Y, Yang T, Zhang Z, Lu M, Zhao W, Zeng X, Zhang W.
    Cancer Sci; 2017 May 25; 108(5):859-867. PubMed ID: 28205334
    [Abstract] [Full Text] [Related]

  • 9. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J.
    J Cell Biochem; 2018 Nov 25; 119(10):8481-8489. PubMed ID: 29987852
    [Abstract] [Full Text] [Related]

  • 10. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF, Dai ZT, Liu WD, Zhao ZX, Kong YH.
    Eur Rev Med Pharmacol Sci; 2019 Feb 25; 23(4):1428-1433. PubMed ID: 30840263
    [Abstract] [Full Text] [Related]

  • 11. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
    Li Y, Zhang T, Zhang Y, Zhao X, Wang W.
    Cancer Sci; 2018 Oct 25; 109(10):3093-3104. PubMed ID: 30099814
    [Abstract] [Full Text] [Related]

  • 12. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z, Cai H, Lin L, Tang M, Cai H.
    Pediatr Blood Cancer; 2014 Feb 25; 61(2):206-10. PubMed ID: 24038809
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ, Guo XJ, Zhao YM, Fang Y.
    Int J Clin Exp Pathol; 2015 Feb 25; 8(11):15138-42. PubMed ID: 26823857
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH, Yang YL, Han SM, Wu ZH.
    World J Surg Oncol; 2014 Jun 27; 12():195. PubMed ID: 24969351
    [Abstract] [Full Text] [Related]

  • 15. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X, Shen Y, Zheng S, Liu J, Jiang X.
    Br J Biomed Sci; 2016 Oct 27; 73(4):158-162. PubMed ID: 27922432
    [Abstract] [Full Text] [Related]

  • 16. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH, Dai J, Shang HL, Zhao ZX, Hao YD.
    Eur Rev Med Pharmacol Sci; 2018 Nov 27; 22(22):7640-7645. PubMed ID: 30536305
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.
    Li TH, Zhang JJ, Liu SX, Chen Y.
    Medicine (Baltimore); 2018 May 27; 97(19):e0575. PubMed ID: 29742691
    [Abstract] [Full Text] [Related]

  • 18. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y, Feng D, Gu X, Gao A, Liu Y.
    Anticancer Drugs; 2021 Feb 01; 32(2):168-177. PubMed ID: 32826416
    [Abstract] [Full Text] [Related]

  • 19. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN, Ge DW, Tang J, Yang J, Yan JW, Qiu JJ, Yin ZW, Ni Y, Zhao L, Chen X, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan 01; 23(1):96-104. PubMed ID: 30657551
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis.
    Zhang Q, Geng PL, Yin P, Wang XL, Jia JP, Yao J.
    Asian Pac J Cancer Prev; 2013 Jan 01; 14(4):2311-5. PubMed ID: 23725133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.